Stored Autologous Blood Transfusion Market to Hit $182.3 Billion by 2033, Driven by Surgical Procedures & Blood Safety Standards | North America leads with 36% Share

Leander, Texas and Tokyo, Japan - Nov.24.2025
As per DataM intelligence research report"The Global Stored Autologous Blood Transfusion Market reached US$149.8 billion in 2024 and is expected to reach US$182.3 billion by 2033, growing at a CAGR of 2.5% during the forecast period 2025-2033". Increasing surgical procedures and the need for safer, personalized blood management are driving adoption of stored autologous transfusion methods.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/stored-autologous-blood-transfusion-market?SaiPrasad

United States: Recent Industry Developments

✅ In November 2025, Haemonetics Corporation expanded its autologous blood management systems with upgraded storage modules that improve red cell viability for perioperative use. The enhancement supports hospitals adopting patient-blood-management protocols. This strengthens Haemonetics' leadership in U.S. transfusion technology.

✅ In October 2025, Fresenius Kabi USA launched advanced autologous blood storage bags with improved anticoagulant stability and extended shelf-life performance. The innovations enable safer reinfusion during major surgeries. This reinforces Fresenius Kabi's position in clinical transfusion solutions.

✅ In September 2025, Terumo Blood and Cell Technologies introduced digital monitoring software for stored autologous blood units, improving traceability and compliance in operating rooms. The system supports precision management for cardiac and orthopedic procedures. This elevates Terumo's presence in patient-specific transfusion care.

✅ In August 2025, Medtronic expanded collaborations with U.S. surgical centers to integrate autologous blood conservation systems within enhanced recovery pathways. The integration reduces donor-blood dependence and improves postoperative outcomes. This strengthens Medtronic's footprint in perioperative blood solutions.

Japan: Recent Industry Developments

✅ In November 2025, Terumo Japan launched next-generation autologous storage systems optimized for Japanese surgical workflows, enabling improved red cell integrity during multi-hour procedures. The update supports hospitals transitioning to advanced blood conservation strategies. This reinforces Terumo's domestic leadership in transfusion technologies.

✅ In October 2025, Sysmex Corporation advanced its autologous blood handling solutions with new quality-control modules ensuring stable hemoglobin recovery during storage. The system boosts accuracy for reinfusion across cardiovascular centers. This solidifies Sysmex's role in Japan's surgical blood management sector.

✅ In September 2025, Nipro Medical Japan expanded production of temperature-stable autologous blood bags through a ¥2.8 billion facility enhancement. The investment aims to meet rising demand from orthopedic and trauma-care hospitals. This strengthens Nipro's manufacturing capability in Japan's transfusion supplies market.

✅ In August 2025, Kawasumi Laboratories introduced improved sterile-closed collection kits for autologous blood storage, designed to reduce contamination risks during preoperative preparation. The kits enhance safety and quality for reinfusion across major hospitals. This supports Kawasumi's position in Japan's clinical infusion devices market.

Stored Autologous Blood Transfusion Market: Drivers
The stored autologous blood transfusion market is witnessing steady growth as healthcare providers increasingly adopt patient-specific blood management strategies to improve safety, reduce transfusion-related risks, and optimize clinical outcomes. Autologous transfusion involves collecting, storing, and reinfusing a patient's own blood, minimizing the risk of infections, immunologic reactions, and compatibility issues associated with allogeneic transfusions. Rising awareness among surgeons, anesthesiologists, and patients about the benefits of autologous blood transfusion in elective surgeries, orthopedic procedures, and cardiac operations is driving adoption. Technological advancements in blood storage solutions, anticoagulants, and transfusion devices are improving the safety, viability, and usability of stored blood. Additionally, regulatory guidelines and hospital protocols promoting blood conservation and patient blood management programs are supporting market expansion.

Collaborations between hospitals, blood banks, and medical device manufacturers are fostering the development of efficient collection, storage, and reinfusion systems. Growing emphasis on minimizing hospital-acquired infections, transfusion-related complications, and allogeneic blood demand is encouraging wider adoption. Expansion of surgical procedures, aging populations, and rising prevalence of chronic conditions that require perioperative blood management are further driving market growth. Integration of digital tracking, inventory management, and quality assurance systems is enhancing process efficiency and patient safety. With increasing awareness, technological innovation, and adoption of patient blood management programs, the stored autologous blood transfusion market is poised for sustained growth globally.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/stored-autologous-blood-transfusion-market?SaiPrasad

Stored Autologous Blood Transfusion Market: Major Players
Terumo Corporation, Haemonetics Corporation, Medtronic, JMS Co. Ltd., Narang Medical Limited., Becton, Dickinson and Company, Fresenius Kabi AG, Nipro, Macopharma and Cardinal Health among others.

Segment Covered in the Stored Autologous Blood Transfusion Market:
By Product Type
Blood collection devices lead with 38% share, driven by increasing adoption in surgeries and preoperative blood management programs. Blood transfusion kits hold 30%, supported by growing demand for safe, standardized transfusion practices. Blood processing products account for 20%, fueled by advancements in blood separation and testing technologies. Blood storage devices capture 12%, primarily used in hospitals and specialized surgical centers.

By Application
Orthopedic surgeries dominate with 35% share, driven by high-risk procedures and preoperative autologous blood collection trends. General surgeries hold 28%, supported by increasing elective procedures and patient safety protocols. Obstetrics & gynecology surgeries account for 22%, benefiting from improved maternal care and blood management practices. Other applications contribute 15%, including trauma and specialized surgical procedures.

By Storage Duration
Short-term storage leads with 62% share, driven by rapid usage in elective surgeries and hospital-based transfusion programs. Long-term storage holds 38%, primarily utilized in blood banks, rare surgeries, and complex surgical procedures. Short-term solutions dominate due to lower cost and ease of integration in clinical workflows.

By Technology
Manual blood collection dominates with 54% share, supported by cost-effectiveness, widespread adoption in hospitals, and compatibility with conventional transfusion practices. Automated blood collection holds 46%, driven by enhanced safety, accuracy, and efficiency in large-volume surgical centers. Automation adoption is rising in advanced healthcare facilities.

Regional Analysis
North America - 36% Share
North America leads with 36%, driven by advanced surgical infrastructure, high elective surgery volumes, and stringent blood safety regulations. The U.S. dominates with strong hospital adoption of autologous transfusion practices.

Europe - 28% Share
Europe holds 28%, supported by well-established blood management protocols, growing orthopedic and gynecology surgeries, and high patient awareness in Germany, France, and the U.K.

Asia Pacific - 24% Share
Asia Pacific accounts for 24%, fueled by rapid expansion of hospitals, increasing surgical procedures, and rising adoption of blood management technologies in China, India, and Japan.

Latin America - 6% Share
Latin America holds 6%, with moderate adoption in Brazil and Mexico due to improving healthcare infrastructure and elective surgery demand.

Middle East - 4% Share
The Middle East accounts for 4%, driven by investments in advanced healthcare facilities and increasing elective surgeries in GCC countries.

Africa - 2% Share
Africa holds 2%, with limited adoption primarily in urban hospitals and specialized surgical centers in South Africa and Nigeria. Growth remains gradual due to infrastructure constraints.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=stored-autologous-blood-transfusion-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?SaiPrasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.